| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 04/20/2011 | CN102020608A Preparation method of 4-benzylquinoline compound |
| 04/20/2011 | CN102020573A Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods |
| 04/20/2011 | CN102020521A Preparation mode and application of deuterium substituted Chinese herbal monomer |
| 04/19/2011 | US7928236 Fluorescent amino acid derivatives |
| 04/13/2011 | CN102015651A Compounds and compositions as TLR activity modulators |
| 04/13/2011 | CN101619039B 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine (blonanserin, Blonanserin) and composition thereof |
| 04/13/2011 | CN101289425B Enantioselective alkylation of tricyclic compounds |
| 04/12/2011 | US7923454 morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide used for preventing or treating viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/07/2011 | US20110079773 Selectively Functionalized Rylene Imides and Diimides |
| 04/06/2011 | EP2305257A1 Amonafide salts and compositions comprising same |
| 04/06/2011 | CN102001998A Process for extracting and purifying magnoflorine from garden columbine family plant |
| 04/06/2011 | CN101151249B 环戊吡啶及四氢喹啉衍生物 Cyclopentyl and tetrahydro-quinoline derivatives of pyridine |
| 04/06/2011 | CN101056861B Carbamoyl-substituted spiro derivative |
| 04/05/2011 | US7919503 P2X7R antagonists and their use |
| 04/05/2011 | US7919493 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 04/05/2011 | CA2467269C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 03/31/2011 | US20110076779 Quinoid rylenedicarboximides as ir absorbers |
| 03/30/2011 | EP2301914A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301913A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301544A1 Quinoline derivatives as intermediates to mycobacterial inhibitors |
| 03/30/2011 | CN101993417A Stable novel crystal form of dimemorfan phosphate |
| 03/30/2011 | CN101712649B Lotus leaf extract, monomer component and application thereof |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/24/2011 | WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof |
| 03/24/2011 | US20110071296 Preparation of 10-Keto Morphinans by Benzylic Oxidation |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110068328 Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof |
| 03/24/2011 | CA2774266A1 Novel tricyclic protein kinase modulators |
| 03/23/2011 | EP2298732A1 7,9-Substituted tetracycline compounds |
| 03/23/2011 | EP2297160A1 Process for the synthesis of n-demethylated morphinane compounds |
| 03/23/2011 | EP2297108A1 Quinoid rylene dicarboximides as ir absorbers |
| 03/23/2011 | EP2297088A2 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode |
| 03/22/2011 | US7910608 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/22/2011 | CA2471628C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
| 03/22/2011 | CA2449215C (pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 03/17/2011 | US20110065843 Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |
| 03/16/2011 | EP2295503A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 03/15/2011 | US7906528 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits |
| 03/15/2011 | CA2502769C 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/10/2011 | US20110059948 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| 03/10/2011 | US20110056562 Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods |
| 03/09/2011 | EP2292586A2 Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods |
| 03/08/2011 | US7902221 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902196 Synthesis of avrainvillamide, strephacidin B, and analogues thereof |
| 03/08/2011 | CA2338504C Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/03/2011 | WO2011024986A1 Organic electroluminescence device |
| 03/03/2011 | US20110054175 System for fluorinating organic compounds |
| 03/03/2011 | US20110053969 Novel diazasipiroakanes and their use for treatment of ccr8 mediated diseases |
| 03/03/2011 | US20110053282 Methods and Kits Using Extended Rhodamine Dyes |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/02/2011 | EP2288596A2 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| 03/01/2011 | US7897766 [3H]-(S,S)-2,2-dimethyl-5-(6-phenyl-pyridazin-3-yl)-5-aza-2-azonia-bicyclo[2.2.1]heptane, iodide; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, mild cognitive impairment, age-associated memory impairment |
| 03/01/2011 | US7897611 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 02/24/2011 | WO2010129057A8 Tetracycline compounds |
| 02/24/2011 | US20110046162 Fused cyanopyridines and the use thereof |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2285780A1 Processes and compounds for the preparation of normorphinans |
| 02/23/2011 | CN101981013A Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
| 02/22/2011 | US7893264 Antiviral phosphinate compounds |
| 02/22/2011 | US7893256 Azabicycloalkane compounds |
| 02/22/2011 | US7893085 3-(4-Bromo-2-fluoro-phenylamino)-thieno[3,2-c]pyridine-2-carboxylic acid (2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-amide; mitogen activated protein extracellular kinase kinase (MEK) inhibitor; antiproliferative, antiinflammatory agent |
| 02/22/2011 | US7893081 Tyrosine kinase inhibitors |
| 02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/17/2011 | US20110039989 Tri- and tetrasubstituted pentarylenetetracarboximides |
| 02/16/2011 | EP2283898A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/16/2011 | CN101973938A C-ring hydrogenated sinomenine derivative and preparation method and application thereof |
| 02/15/2011 | US7888863 Organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/15/2011 | US7888509 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 02/15/2011 | US7888351 Organic compounds |
| 02/15/2011 | CA2457671C Process for the preparation of a 14-hydroxynormorphinone derivative |
| 02/10/2011 | US20110034455 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 02/10/2011 | US20110034446 R(-)-2-methoxy-11-hydroxyaporphine and derivatives thereof |
| 02/09/2011 | CN101967124A Separation and purification method for lappaconitine |
| 02/08/2011 | CA2586179C Sulfonyl benzimidazole derivatives |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/03/2011 | WO2011014003A2 (+)-3-hydroxymorphinan derivatives as neuroprotectants |
| 02/03/2011 | US20110028724 Polymers of napthalene tetracarboxylic diimide dimers |
| 02/03/2011 | US20110027264 Gamma secretase modulators for the treatment of alzheimer's disease |
| 02/01/2011 | CA2560547C Formamide derivatives useful as adrenoceptor |
| 02/01/2011 | CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 02/01/2011 | CA2351707C Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| 01/27/2011 | WO2011010843A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/26/2011 | EP2044029B1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 01/26/2011 | CN101955459A Method for preparing blonanserin |
| 01/25/2011 | US7875721 Modulators of estrogen receptor alpha/beta G protein-coupled receptor 30, e.g., 1-(4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)1-ethanone; treating diseases such as cancer, neurodegenerative disorders, obesity, osteoporosis, and symptoms of menopause |
| 01/25/2011 | US7875720 Antiscaling agents; the monomer N-allyl-4-(2-N',N'-dimethylaminoethoxy)naphthalimide, methyl sulfate quaternary salt |
| 01/25/2011 | US7875630 reacting exo-8-methyl-8-azabicyclo[3.2.1]octan-3-thiol with mutilin 14-methanesulfonyloxyacetate in the presence of a tetra-n-butylammonium hydrogensulfate phase transfer catalyst, 4-methyl-2-pentanone, and aqueous NaOH to form mutilin 14-(exo-8-methyl-8-azabicyclo[3.2. 1]oct-3-ylsulfanyl)-acetate |
| 01/25/2011 | US7875625 3-guanidinocarbonyl-2-methyl-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ylmethyl hydrogen sulfate, inhibitory effect on an Na+/H+ exchanger; |
| 01/25/2011 | US7875603 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian |
| 01/25/2011 | CA2506648C 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 01/20/2011 | WO2011009015A1 (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/20/2011 | US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |